VYNE (VYNE THERAPEUTICS INC) — 3 tracked funds

Cross-fund · 3 holders

VYNE

VYNE THERAPEUTICS INC

CUSIP 92941V308

Tracked holders

$516,348

Aggregate value

873,393

Active funds

Funds holding VYNE

Fund	Strategy	Period	Value	% of book	Δ shares	Status
Citadel	Multi-Strategy	Q1 2026	$307,380	—	+483,917	+1585.3%
Vanguard	Institutional	Q4 2025	$182,436	—	+124,162	+65.2%
BlackRock	Institutional	Q1 2026	$26,532	—	0	HELD

Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.